NORTH PERTH – Ontario announced on Sept. 24 it is now providing coverage for Trikafta, the latest and most effective treatment option for cystic fibrosis (CF) to become available, under its publicly-funded drug program to give patients more access to life-changing treatments. Local parents Shane and Sarah Van Allen, whose eight-year-old son Wade was diagnosed…
To access this post, you must purchase Digital Subscription - Monthly or Digital Subscription - Yearly.
Gain full access by subscribing - Subscribe Now
Already a member?Please login to get full access.
Gain full access by subscribing - Subscribe Now
Already a member?Please login to get full access.
